<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03861507</url>
  </required_header>
  <id_info>
    <org_study_id>6442</org_study_id>
    <nct_id>NCT03861507</nct_id>
  </id_info>
  <brief_title>Needle Localization During Prostate Brachytherapy Using Power Doppler Ultrasound</brief_title>
  <official_title>Needle Localization During Prostate Brachytherapy Using Power Doppler Ultrasound</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Western University, Canada</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Western University, Canada</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study involves patients who are scheduled for standard care brachytherapy of focal
      tumours within the prostate, which is normally performed under standard 2-dimensional (2D)
      ultrasound guidance. The purpose of this study is the acquire power Doppler ultrasound while
      using a simple oscillator in physical contact with the end of a brachytherapy needle. The
      vibrations along the needle should be visible in the power Doppler ultrasound, helping to
      visualize the needle position within the anatomy.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 4, 2020</start_date>
  <completion_date type="Anticipated">July 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Needle Trajectory</measure>
    <time_frame>1 month following data collection</time_frame>
    <description>Intra-operative needle trajectories in B-mode and power Doppler ultrasound</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Prostate Cancer</condition>
  <arm_group>
    <arm_group_label>Patient</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Patient undergoing standard care prostate high dose rate brachytherapy.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Prostate Brachytherapy</intervention_name>
    <description>High dose - rate (HDR) brachytherapy</description>
    <arm_group_label>Patient</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male, aged 18 years or older

          -  Willing to provide written consent

          -  Pathologically confirmed prostate cancer on previous biopsy

          -  Suitable for and consenting to high-dose-rate brachytherapy for treatment as standard
             of care.

        Exclusion Criteria:

          -  â€¢ Previous radiotherapy to the prostate
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Aaron Fenster</last_name>
    <phone>5199315777</phone>
    <phone_ext>5199315777</phone_ext>
    <email>afenster@uwo.ca</email>
  </overall_contact>
  <location>
    <facility>
      <name>Victoria Hospital</name>
      <address>
        <city>London</city>
        <state>Ontario</state>
        <zip>N6A 5W9</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Douglas Hoover, PhD</last_name>
      <email>Douglas.Hoover@lhsc.on.ca</email>
    </contact>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>February 28, 2019</study_first_submitted>
  <study_first_submitted_qc>February 28, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">March 4, 2019</study_first_posted>
  <last_update_submitted>March 11, 2020</last_update_submitted>
  <last_update_submitted_qc>March 11, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 16, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Western University, Canada</investigator_affiliation>
    <investigator_full_name>Aaron Fenster</investigator_full_name>
    <investigator_title>Medical Biophysics Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Prostatic Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

